SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 5 filers reported holding SUMMIT THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LANSDOWNE PARTNERS (UK) LLP | 1,596,666 | $3,545,000 | 0.04% |
| Fusion Family Wealth LLC | 29,000 | $64,000 | 0.02% |
| Polar Capital LLP | 350,000 | $777,000 | 0.01% |
| Point72 Asset Management, L.P. | 464,630 | $1,031,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 172,952 | $384,000 | 0.00% |
| JPMORGAN CHASE & CO | 15,144 | $34,000 | 0.00% |
| Renaissance Technologies | 38,700 | $86,000 | 0.00% |
| ROYAL BANK OF CANADA | 11,000 | $24,000 | 0.00% |
| UBS Group AG | 457 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |